Stocks
Avanos Medical (AVNS) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -0.28% | 1.20% | 15.0% | 9.49% | 7.90% | 14.2% | ||
| Changes by years, y/y, % | +1pp | +1pp | +14pp | -5pp | -2pp | +4.3% | |||
Avanos Medical. EBITDA margin, %
Avanos Medical. EBITDA margin, changes, pp
Avanos Medical (AVNS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 7.65% | 17.5% | 11.4% | 13.4% | 14.3% | 14.2% | |
| Changes by years, y/y, % | -7pp | -1pp | +3pp | +8pp | +7pp | |||
| Changes by quarters, q/q, % | +2pp | +10pp | -6pp | +2pp | +1pp | |||
